Top Clinical Trials Companies Revolutionizing Research in 2025
21 May, 2025

The Global Clinical Trials Market is expected to increase at a compound annual growth rate (CAGR) of 6.07% from 2025 to 2033, from $58.39 billion in 2024 to $99.25 billion by 2033. Similarly, at a compound annual growth rate (CAGR) of 6.00% from 2025 to 2033, the North America Clinical Trials Market is projected to grow from US$ 20.07 billion in 2024 to US$ 33.91 billion by 2033.

The market for clinical trials worldwide is expanding quickly due to rising chronic illnesses, increased demand for novel medications, and higher R&D expenditures. Growth is further accelerated by worldwide outsourcing, decentralized testing, and technological breakthroughs. North America holds the top spot, while Asia-Pacific comes in second because to its lower costs and growing healthcare system. Another factor anticipated to drive growth in the clinical trial services market is the growing practice of pharmaceutical firms outsourcing clinical trials in order to concentrate on their core capabilities. For example, Divergent CRO launched an own contract research company in the US in February 2024. By offering pharma and biotechnology businesses customized clinical services, this CRO seeks to revolutionize the R&D process. Similar to this, PQE Group established an internal Contract Research Organization (CRO) in October 2023 using a ground-breaking approach. Therefore, it is anticipated that these expanding CROs that provide clinical trial services to pharmaceutical corporations would aid in market expansion in the years to come.

Prominent firms in the clinical trials industry offer comprehensive services, such as data analysis, patient recruiting, study design, and regulatory assistance. Through cutting-edge technology and strategic alliances across a range of therapeutic disciplines, they promote efficiency, shorten development times, and assist international research.

Discover key trends, growth opportunities, and major challenges shaping the Clinical Trials Industry in Renub Research’s latest in-depth market report. Download your free sample now

Leading CROs and Clinical Trials Providers Shaping the Future

ICON Plc

Establishment: 1990

Headquarters: Ireland

Website: www.iconplc.com

Revenue: $8.3B in 2023

A contract research organization (CRO), ICON Plc (ICON) offers development services to the pharmaceutical, medical device, and biotechnology sectors globally. The business offers specialist services covering every stage of product development. Adaptive trials, biosimilars, clinical research services, commercialization and results, consulting, functional services, medical imaging, resourcing solutions, laboratory services, and tactical and strategic support for conventional in vitro diagnostic and software devices are all included in ICON's service portfolio. Cancer, genomics, the central nervous system, cardiovascular disease, endocrine and metabolic disorders, gastrointestinal disorders, medical devices, non-alcoholic steatohepatitis (NASH), ophthalmology, rare and orphan diseases, immunology and transplantation, vaccines, and women's health are among the fields in which the company provides research services. The headquarters of ICON are located in Dublin, Ireland.

Wuxi AppTec

Establishment: 2000

Headquarters: China

Website: www.wuxiapptec.com

Revenue: $5.5B in 2023

The pharmaceutical business WuXi AppTec Co Ltd (WuXi AppTec) offers manufacturing and research & development services. The business provides biological services such oncology, analytical, integrated drug discovery, hit finding, and discovery biology. Research chemistry services as well as development and manufacturing services are provided by its small molecule (contract research, development, and manufacturing organization, CRDMO). WuXi AppTec offers safety evaluation, bioanalytical, and DMPK services for drug research and development testing. Clinical research services offered by the organization include consultation, quality system management, medical affairs, and regulatory affairs. Its comprehensive end-to-end contract research, development, and manufacturing organization (CRDMO) platform is used to deliver services. The business caters to the biotech, pharmaceutical, and medical device sectors. The headquarters of WuXi AppTec are located in Shanghai, China.

SGS SA

Establishment: 1878

Headquarters: Switzerland

Website: www.sgs.com/en

Revenue: $7.7B in 2023

Inspection, verification, testing, certification, and quality assurance services are all offered by SGS SA (SGS). In addition, the business offers training, sustainable solutions, consulting, and risk management. SGS verifies that raw materials, components, and finished goods adhere to local regulatory requirements, such as tax and tariff, as well as industry standards by inspecting, sampling, analyzing, and monitoring them. Chemical, oil and gas, construction, energy, life sciences, arts and culture, mining, public sector, logistics, industrial manufacturing, consumer goods and retail, environment, and transportation are just a few of the industries that the firm supports. In Europe, Africa, the Middle East, the Americas, and Asia Pacific, it runs a network of offices and labs. Geneva, Switzerland, is home to SGS's headquarters.

Syneos Health

Establishment: 1998

Headquarters: United States of America

Website: www.syneoshealth.com

Revenue: $5.4B in 2023

Previously INC Research Holdings Inc., Syneos Health Inc. (Syneos Health) is a biopharmaceutical services company that provides commercial solutions and product development. The business offers clinical research services from Phase I to Phase IV, including data administration, full-service international trials, clinical monitoring, patient and investigator recruiting, and more. Consulting services, medication adherence, and communications are among its business offerings. Large and small to mid-sized businesses in the biotechnology, biopharmaceutical, and medical device sectors can use Syneos Health's products. The business has operations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. The US city of Morrisville, North Carolina, is home to Syneos Health's headquarters.

PRA Health Sciences Inc.

Establishment: 1976

Headquarters: United States of America

Website: prahs.com

Revenue: $3.2B in 2023

ICON Plc's subsidiary PRA Health Sciences Inc. is a contract research organization (CRO) that offers data solution and clinical development services that are outsourced. The business provides a range of services, including clinical pharmacology, data management, statistical analysis, regulatory and drug development consultation, risk-based monitoring, site identification and selection, medical writing, validation, commercialization, and asset valuation. The US city of Raleigh, North Carolina, is home to the company's headquarters.

Pfizer Inc.

Establishment: 1849

Headquarters: United States of America

Website: www.pfizer.com

Revenue: $63.6B in 2023

Pfizer Inc. is a biopharmaceutical firm that focuses on research. It finds, creates, produces, sells, and distributes medications and vaccines. Anti-infectives, cancer, cardiology, diabetes, obesity, inflammation, immunology, uncommon disorders, and bacterial infections are just a few of the therapeutic areas that the company's medicines address. Healthcare professionals, hospitals, clinics, and pharmacies utilize Pfizer's medicines to treat a range of illnesses. With names including Zavzpret, Abrysvo, Inflectra, Genotropin, Octagam, and Bosulif, among others, the corporation sells its goods through a network of wholesalers, merchants, and government organizations. Among other countries, it runs production facilities in Belgium, Germany, India, Ireland, Italy, Japan, Singapore, and the United States. The US city of New York is home to Pfizer's headquarters.

IQVIA

Establishment: 1982

Headquarters: United States of America

Website: ir.iqvia.com

Revenue: $15.4B in 2023

IQVIA Holdings Inc. (IQVIA) is a multinational provider of clinical research services, healthcare analytics, and commercial insights to the healthcare and life sciences sectors. The business provides a variety of IQVIA Connected Intelligence-powered products, such as sophisticated analytics, healthcare-grade AI, high-quality health data, and technological infrastructure. Real-world solutions, analytics-driven clinical development, and a variety of patented clinical and commercial applications are among the company's primary offerings. Governmental organizations and healthcare stakeholders, as well as biotech, pharmaceutical, and medical device firms, use IQVIA solutions. The business operates in Africa, Asia, Europe, and the Americas. The US headquarters of IQVIA are located in Durham, North Carolina.

Sanofi

Establishment: 1973

Headquarters: France

Website: www.sanofi.com

Revenue: $47.9B in 2023

The healthcare business Sanofi is involved in the research, development, production, and distribution of a variety of medications and vaccines. Its product line includes vaccinations for humans to protect against a variety of bacterial and viral illnesses, medications to treat cancer, uncommon disorders, and multiple sclerosis, and other items. In addition, the firm sells consumer health goods for women's health, allergies, cough, cold, flu, and sinuses, pain, and vitamins, minerals, and supplements. Sanofi's research and development activities are concentrated on developing a combination medication to boost treatment efficacy and on developing novel biologics formulations to create precision medications. It operates in the Middle East, Asia-Pacific, Africa, the Americas, and Europe. The headquarters of Sanofi are located in Paris, France's Ile-de-France.

Medpace

Establishment: 1992

Headquarters: United States of America

Website: investor.medpace.com

Revenue: $2.1B in 2023

Outsourced clinical development services are offered by Medpace Holdings Inc. (Medpace), a clinical research organization (CRO). In addition to project management, regulatory affairs, data management, clinical monitoring, and post-market clinical support, it offers full-service Phase I to Phase IV clinical trial services. In addition, the business offers a range of imaging services, bio-analytical laboratory services, clinical human pharmacology, and assistance with ECG readings. Cardiology, metabolic disorders, endocrinology, central nervous system (CNS), cancer, and antiviral and anti-infective (AVAI) illnesses are among the ailments for which Medpace conducts clinical studies of pharmaceuticals. In North America, Asia, South America, Europe, Africa, and Australia, it provides services to pharmaceutical, biotechnology, biopharmaceutical, and medical device firms. The US city of Cincinnati, Ohio, is home to Medpace's headquarters.